PMV Pharmaceuticals, Inc. (PMVP) Misses Q2 EPS by 2c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q2 EPS of ($0.41), $0.02 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• Guggenheim Reiterates Neutral Rating on Advance Auto Parts (AAP)
• Trustar Bank to acquire Forbright Bank branches for $750M in deposits